Trial Profile
A Study to Evaluate the Co-Administration of MK-4618 With Antihypertensive Agents
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Vibegron (Primary) ; Amlodipine; Metoprolol
- Indications Hypertension; Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Merck Sharp & Dohme Corp.
- 06 Dec 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
- 06 Dec 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Jul 2011 Planned end date changed from 1 Aug 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.